medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2019, Number 1

<< Back Next >>

Cir Plast 2019; 29 (1)

Management of chronic seroma in patients with breast implants in relation to the diagnosis of anaplastic lymphoma of giant cells

Ramos-Gallardo G, Ríos-Lara y López RL, Cuenca-Pardo J, Cárdenas-Camarena L, Contreras-Bulnes L, Vélez BE, Bucio-Duarte J, Pineda-Espinosa MA, Ugalde VA, Avendaño-Peza HM

Language: Spanish
References: 34
Page: 147-162
PDF size: 354.44 Kb.


ABSTRACT

In recent years, we have acquired more knowledge about a rare disease related to breast implants: the giant anaplastic lymphoma. Although there are few cases, and the incidence is variable, we want to mention what we have done in our country in this regard and the measures we suggest to handle a possible case. It is important to mention that not all cases of chronic seroma have been related to lymphoma. Therefore, we explain what should be done in a suspected case, how to handle a seroma when the diagnosis is negative for BIA-ALCL and recommend that implants should not be removed or changed in asymptomatic patients, at that time. Finally, as an annex to this article, the infographic on the subject made by the Safety Committee are added to guide plastic surgeons, health personnel and patients.


REFERENCES

  1. Cook PD, Osborne BM, Connor RL et al. Follicular lymphoma adjacent to foreign body granulomatous inflammation and fibrosis surrounding silicone breast prosthesis. Am J Surg Pathol 1995; 19 (6): 712-717.

  2. Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. PRS 1997; 100 (2): 554-555.

  3. Ramos-Gallardo G, Cuenca-Pardo J, Rodríguez-Olivares E, Iribarren-Moreno R, Contreras-Bulnes L, Vallarta-Rodríguez A et al. Breast implant and anaplastic large cell lymphoma meta-analysis. J Invest Surg 2017; 30 (1): 56-65.

  4. Torres-Rivero C, Ramos-Gallardo G, Nambo-Lucio M, Vaquero-Pérez M. First case report in Mexico and Latin America of anaplastic large cell lymphoma in a patient with mammary implants. Cir Plast Iberolatinoam 2016; 42 (2): 175-180.

  5. Ramos-Gallardo G, Cuenca-Pardo J, Cardenas-Camarena L, Duran-Vega H, Rodríguez-Olivares E, Bayter-Marin JE et al. Is Latin America Ready to Identify Anaplastic Large Cell Lymphoma in Breast Implants Patients? Regional Encounter during the National Plastic Surgery Meeting in Cancun, Mexico. Aesth Plast Surg 2018; 42 (5): 1421-1428.

  6. Srinivasa D, Miranda RN, Kaura A, Francis AM, Campanale A, Boldrini R. Global Adverse Event Reports of Breast Implant Associated ALCL An International Review of 40 Government Authority Databases. PRS 2017; 139 (5): 1029-1039.

  7. Sanchez-Gonzalez B, Garcia M, Ferran M, Sanchez M, Angona A, Salar AS. Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation In Metallic Implant. J Clin Oncol 2013; 31 (10): e148-e151.

  8. Sunitsch S, Gilg M, Kashofer K, Leithner A, Liegl-Atzwanger B, Beham-Schmid C. Case Report: Epstein-Barr-Virus negative diffuse large B-cell lymphoma detected in a periprosthetic membrane. Diag Pathol 2016; 11 (1): 80-86.

  9. Miller DV, Firchau DJ, McClure RF, Kurtin PJ, Feldman AL. Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma Arising on Cardiac Prostheses. Am J Surg Pathol 2010; 34 (3): 377-384.

  10. Jin SH, Park G, Ko Y, Park JB. Diffuse Large B-Cell Lymphoma of the Peri-Implant Mucosa Mimicking Peri-Implants. J Oral Implantol 2016; 42 (2): 220-223.

  11. Lee SH, Kim HC, Kim YJ. B-Cell Lymphoma in a Patient with a History of Foreign Body Injection. J Craniofac Surg 2017; 28 (2): 504-505.

  12. Umakanthan MJ, McBride CL, Greiner Y, Yuan J, Sanmann J, Bierman PJ, Lunning MA, Bociek RG. Bariatric Implant–Associated Anaplastic Large-Cell Lymphoma. J Oncol Prac 2017; 13: 838-840.

  13. Adams WP, Bengtson BP, Glicksman CA et al. Decision and management algorithms to address patient and food and drug administration concerns regarding breast augmentation and implants. Plast Reconstr Surg 2004; 114: 1252-1257.

  14. Gabriel SE, Woods JE, O’Fallon WM, Beard CM, Kurland LT, Melton LJ III. Complications leading to surgery after breast implantation. N Engl J Med 1997; 336: 677-682.

  15. Alobeid B, Sevilla DW, El-Tamer MB, Murty VV, Savage DG, Bhagat G. Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma 2009; 50: 831-833.

  16. Pinchuk V, Tymofii O. Seroma as a late complication after breast augmentation. Aesth Plast Surg 2011; 35 (3): 303-14

  17. Miranda RN, Lin L, Talwalkar SS, Manning JT, Medeiros LJ. Anaplastic large cell lymphoma involving the breast: A clinic pathologic study of 6 cases and review of the literature. Arch Pathol Lab Med 2009; 133: 1383-1390.

  18. Chourmouzi D, Vryzas T, Drevelegas A. New spontaneous breast seroma 5 years after augmentation: A case report. Cases J 2009; 2: 7126.

  19. Oliveira VM, Roveda Junior D, Lucas FB et al. Late seroma after breast augmentation with silicone prostheses: A case report. Breast J 2007; 13: 421-423.

  20. de Jong D, Vasmel WL, de Boer JP et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008; 300: 2030-2035.

  21. Do V, Shifrin DA, and Oostendorp L. Lymphoma of the breast capsule in a silicone implant-reconstructed patient. Am Surg 2010; 76: 1030-1031.

  22. Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP. Lymphomas of the breast: Primary and secondary involvement. Cancer 2002; 94: 6-13.

  23. Thompson PA, Lade S, Webster H, Ryan G, Prince HM. Effusion-associated anaplastic large cell lymphoma of the breast: Time for it to be defined as a distinct clinicopathological entity. Haematologica 2010; 95: 1977-1979.

  24. Falini B, Martelli MP. Anaplastic large cell lymphoma: Changes in the World Health Organization classification and perspectives for targeted therapy. Haematologica 2009; 94: 897-900.

  25. Falini B, Pileri S, Zinzani PL et al. ALK lymphoma: Clinicopathological findings and outcome. Blood 1999; 93: 2697-2706.

  26. Li S, Lee AK. Silicone implant and primary breast ALK-1 negative anaplastic large cell lymphoma, fact or fiction. Int J Clin Exp Pathol 2010; 3: 117-127.

  27. Farkash EA, Ferry JA, Harris NL et al. Rare lymphoid malignancies of the breast: A report of two cases illustrating potential diagnostic pitfalls. J Hematop 2009; 2: 237-244.

  28. Fodor L, Moscona R. Late post-traumatic intracapsular seroma after breast augmentation. J Plast Reconstr Aesthet Surg 2009; 62: e609-e610.

  29. Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA, Chadburn A. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: A case report and review of the literature. Arch Pathol Lab Med 2003; 127: e115-e118.

  30. Gaudet G, Friedberg JW, Weng A, Pinkus GS, Freedman AS. Breast lymphoma associated with breast implants: Two case reports and a review of the literature. Leuk Lymphoma 2002; 43: 115-119.

  31. Bengtson BP. Complications, reoperations, and revisions in breast augmentation. Clin Plast Surg 2009; 36: 139-156.

  32. Hasham S, Akhtar S, Fourie LR. Persistent seroma following breast prosthesis explantation: A case report and review. Eur J Plast Surg 2006; 28: 490-493.

  33. Newman MK, Zemmel NJ, Bandak AZ, Kaplan BJ. Primary breast lymphoma in a patient with silicone breast implants: A case report and review of the literature. J Plast Reconstr Aesthet Surg 2008; 61: 822-825.

  34. Henriksen TF, Hölmich LR, Fryzek JP et al. Incidence and severity of short-term complications after breast augmentation: Results from a nationwide breast implant registry. Ann Plast Surg 2003; 51: 531-539.




2020     |     www.medigraphic.com